1. Xie , C. Two-way bridging clinical pharmacology. Key issues on clinical pharmacology and regulatory requirements for clinical drug development in China and the US 2013
2. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the US: an FDA perspective;Khin;Clin. Pharmacol. Ther.,2013
3. Trial geography, pharmacogenetics and global drug development;Schuck;Clin. Pharmacol. Ther.
4. Racial/ethnic differences in drug disposition and response: review of recently approved drugs;Ramamoorthy;Clin. Pharmacol. Ther.
5. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective;Jones;Clin. Pharmacol. Ther.